United States · FDA National Drug Code directory
tofacitinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-1353_e36ed3d6-ca72-49fe-beb1-3506a7e53990
- Product NDC
- 70710-1353
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- tofacitinib
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260520
- Source listing expiry
- 20271231
Source-listed ingredients
- TOFACITINIB CITRATE — 11 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70710-1353-3) · 70710-1353-3
- 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70710-1353-9) · 70710-1353-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →